Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brest University Hospital, Brest, France
Researchers' data from France, Norway and Austria advance imaging research
August 18th, 2006
Data on imaging are outlined in reports from France, Norway and Austria. Study 1: MSCT-based coronary angiography may serve as an alternative to invasive coronary angiography to rule out significant coronary artery disease in patients scheduled for elective aortic valve replacement. In a recently published study, investigators in France reported, "To evaluate multislice computed tomography (MSCT) as an alternative to coronary angiography, we prospectively studied its diagnostic accuracy for the detection of significant coronary artery lesions in patients with significant aortic valve stenosis undergoing valve surgery. In patients with aortic valve...
Source: Biotech Law Weekly (2006-08-18)
|
